Citations Report
Clinical Investigation : Citations & Metrics Report
Articles published in Clinical Investigation have been cited by esteemed scholars and scientists all around the world.
Clinical Investigation has got hindex 25, which means every article in Clinical Investigation has got 25 average citations.
Following are the list of articles that have cited the articles published in Clinical Investigation.
2021  2020  2019  2018  2017  

Year wise published articles 
60  28  19  22  19 
Year wise citations received 
231  169  96  67  60 
Journal total citations count  2998 
Journal impact factor  9.25714285 
Journal 5 years impact factor  12.6985645 
Journal cite score  13.6644295 
Journal hindex  25 
Journal hindex since 2018  20 
Journal Impact Factor 2020 formula 
IF= Citations(y)/{Publications(y1)+ Publications(y2)} Y= Year 
Journal 5year Impact Factor 2020 formula 
Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} 
Journal citescore 
Citescore_{y} = Citations_{y} + Citations_{y1} + Citations_{y2} + Citations _{y3} / Published articles_{y} + Published articles_{y1} + Published articles_{y2} + Published articles _{y3} 

Maraki S, Samonis G, Karageorgopoulos DE, Mavros MN, Kofteridis D, et al. ( 2012) In vitro antimicrobial susceptibility to isepamicin of 6296 Enterobacteriaceae clinical isolates collected at a tertiarycare University Hospital in Greece. Antimicrobial agents and chemotherapy Mar 5:AAC06358.
View at Publisher  View at Google Scholar 
Hanberger H, Giske CG, Giamarellou H (2011) When and how to cover for resistant gramnegative bacilli in severe sepsis and septic shock. Current infectious disease reports 13(5):416.
View at Publisher  View at Google Scholar  Melchers MJ, van Mil AC, Mouton JW (2015) In vitro activity of ceftolozane alone and in combination with tazobactam against extendedspectrumβlactamaseharboring Enterobacteriaceae. Antimicrobial agents and chemotherapy 59(8):45215. View at Publisher  View at Google Scholar  View at Indexing

Stockfleth E, Sibbring GC, Alarcon I (2016) New topical treatment options for actinic keratosis: a systematic review. Acta dermatovenereologica 96: 1723.
View at Publisher  View at Google Scholar  Del Rosso JQ, Kircik L, Goldenberg G, Brian B (2014) Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach. The Journal of clinical and aesthetic dermatology (9 Suppl S2S12): S2. View at Publisher  View at Google Scholar  View at Indexing
 Rosso JQ (2016) Ingenol Mebutate Topical Gel. Journal of Clinical & Aesthetic Dermatology 9. View at Publisher  View at Google Scholar  View at Indexing
 Wadi J, Haloub N, Al Ahmad M, Samara A, Romman A (2011) Prevalence of meropenem susceptibility among Gramnegative pathogens isolated from intensive care units in Jordan. The International Arabic Journal of Antimicrobial Agents 1(1). View at Publisher  View at Google Scholar  View at Indexing
 Mottaghi K. Structurebased Development of Vitamin B5 Analogs and Evaluation of Their Antimicrobial Efficiency against S. aureus and E. coli (Doctoral dissertation, University of Toronto). View at Publisher  View at Google Scholar  View at Indexing

ChávezTapia NC, Ridruejo E, Alves de Mattos A, Bessone F, Daruich J, et al. An update on the management of hepatitis C: guidelines for protease inhibitorbased triple therapy from the Latin American Association for the Study of the Liver. Ann Hepatol 12: S3S5.
View at Publisher  View at Google Scholar 
Ridruejo E (2014) Safety of directacting antivirals in the treatment of chronic hepatitis C. Expert opinion on drug safety 13: 307319.
View at Publisher  View at Google Scholar  ADISON WC. Programming microbes to treat superbug infection (Doctoral dissertation, Nanyang Technological University). View at Publisher  View at Google Scholar  View at Indexing
 Liapikou A, Cilloniz C, Mensa J, Torres A (2015) New antimicrobial approaches to gram positive respiratory infections. Pulmonary pharmacology & therapeutics 32: 137143. View at Publisher  View at Google Scholar  View at Indexing
 é«˜ä¼šæ´², æÂ¨ç§‘æ¦. è¶…çº§ç»†èÂŒè€ÂèÂ¯éÂ¶é…¶é‡‘å±Å¾ βå†…é…°èƒºé…¶çš„ç ”ç©¶è¿›å±•. ä¸å›½èÂ¯å¦æÂ‚å¿—. 2012;47(5):32530. View at Publisher  View at Google Scholar  View at Indexing
 Liapikou A, Torres A (2013) Emerging drugs on methicillinresistant Staphylococcus aureus. Expert opinion on emerging drugs 18: 291305. View at Publisher  View at Google Scholar  View at Indexing
 Liapikou A, RosalesMayor E, Torres A (2014) Pharmacotherapy for hospitalacquired pneumonia. Expert opinion on pharmacotherapy 15: 775786. View at Publisher  View at Google Scholar  View at Indexing
 Liapikou A, Dimakou K, Toumbis M (2016) Telavancin in the treatment of Staphylococcus aureus hospitalacquired and ventilatorassociated pneumonia: clinical evidence and experience. Therapeutic Advances in Respiratory Disease 10: 368378. View at Publisher  View at Google Scholar  View at Indexing

Kim C, Yang H, Fukushima Y, Saw PE, Lee J, et al. (2014) Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption. Cancer cell 25: 102117.
View at Publisher  View at Google Scholar  Stephen S, Baranova A, Younossi ZM (2012) Nonalcoholic fatty liver disease and bariatric surgery. Expert review of gastroenterology & hepatology 6(2):16371. View at Publisher  View at Google Scholar  View at Indexing

Sanghai N, Jain V, Preet R, Kandekar S, Das S, et al. ( 2014) Combretastatin A4 inspired novel 2aryl3arylaminoimidazopyridines/pyrazines as tubulin polymerization inhibitors, antimitotic and anticancer agents. MedChemComm 5: 766782.
View at Publisher  View at Google Scholar 
Devkota L, Lin CM, Strecker TE, Wang Y, Tidmore JK, et al. (2016) Design, synthesis, and biological evaluation of watersoluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberenebased parent vascular disrupting agents. Bioorganic & medicinal chemistry 24: 938956.
View at Publisher  View at Google Scholar 
Rezazadeh A, Yazdanparast R, Molaei M (2012) Amelioration of dietinduced nonalcoholic steatohepatitis in rats by Mnsalen complexes via reduction of oxidative stress. Journal of biomedical science 19(1):26.
View at Publisher  View at Google Scholar 
Stocker V, Ghinet A, Leman M, Rigo B, Millet R, et al. (2013) On the synthesis and biological properties of isocombretastatins: a case of ketone homologation during Wittig reaction attempts. RSC Advances 3: 36833696.
View at Publisher  View at Google Scholar 
Yan GH, Li XF, Ge BC, Shi XD, Chen YF, et al. (2015) Synthesis and anticancer activities of 3arylflavone8acetic acid derivatives. European journal of medicinal chemistry 90: 251257.
View at Publisher  View at Google Scholar  Xin HG, Zhang BB, Wu ZQ, Hang XF, Xu WS et al. (2014) Treatment with baicalein attenuates methionine− choline deficient dietinduced nonalcoholic steatohepatitis in rats. European journal of pharmacology 738:3108. View at Publisher  View at Google Scholar  View at Indexing
 Herdman CA, Devkota L, Lin CM, Niu H, Strecker TE, et al. (2015) Structural interrogation of benzosuberenebased inhibitors of tubulin polymerization. Bioorganic & medicinal chemistry 23: 7497520. View at Publisher  View at Google Scholar  View at Indexing

Shi TT, Li G, Xiao HT (2016) The Role of RhoJ in Endothelial Cell Biology and Tumor Pathology. BioMed Research International 2016.
View at Publisher  View at Google Scholar  Baguley BC, McKeage MJ (2014) Therapeutic targeting of tumor angiogenesis: how far have we come?. Clinical Investigation 4: 11131122. View at Publisher  View at Google Scholar  View at Indexing
 Wang W, Zhou W, Wang B, Zhu H, Ye L et al. (2012) Antioxidant effect of apolipoprotein AI on highfat dietinduced nonalcoholic fatty liver disease in rabbits. Acta biochimica et biophysica Sinica Nov 21:gms100 View at Publisher  View at Google Scholar  View at Indexing

Herdman CA, Strecker TE, Tanpure RP, Chen Z, Winters A, et al. (2016) Synthesis and biological evaluation of benzocyclooctenebased and indenebased anticancer agents that function as inhibitors of tubulin polymerization. MedChemComm 7: 24182427.
View at Publisher  View at Google Scholar  Koh GY, Kim C, Yang H, Do Heo W, Kim I, et al. (2014) inventors; Korea Advanced Institute Of Science, Technology (Kaist), assignee. Method for targeting vascular rhoj for inhibiting tumor angiogenesis. United States patent application US 14/271,117. View at Publisher  View at Google Scholar  View at Indexing

ÃâÃÂ°ÃÂ¹Ãâ¡ÃÂµÃÂ½ÃÂºÃÂ¾ ÃÅ¾Ãâ¢. ÃÂ¢ÃÂµÃâ¬ÃÂ°ÃÂ¿ÃÂµÃÂ²ÃâÃÂ¸Ãâ¡ÃÂµÃÂÃÂºÃÂ¸ÃÂµ ÃÂ¼ÃÂ¸ÃËÃÂµÃÂ½ÃÂ¸ ÃÂ¿Ãâ¬ÃÂ¸ ÃÂ½ÃÂµÃÂ°ÃÂ»ÃÂºÃÂ¾ÃÂ³ÃÂ¾ÃÂ»ÃÅÃÂ½ÃÂ¾ÃÂ¹ ÃÂ¶ÃÂ¸Ãâ¬ÃÂ¾ÃÂ²ÃÂ¾ÃÂ¹ ÃÂ±ÃÂ¾ÃÂ»ÃÂµÃÂ·ÃÂ½ÃÂ¸ ÃÂ¿ÃÂµÃâ¡ÃÂµÃÂ½ÃÂ¸. ÃÂ¡ÃÆÃâ¡ÃÂ°ÃÂÃÂ½ÃÂ° ÃÂ³ÃÂ°ÃÂÃâÃâ¬ÃÂ¾ÃÂµÃÂ½ÃâÃÂµÃâ¬ÃÂ¾ÃÂ»ÃÂ¾ÃÂ³ÃâÃÂ. 2014(1):1308.
View at Publisher  View at Google Scholar  Ð¡Ñ‚ÐµÐ¿Ð°Ð½Ð¾Ð² Ð®Ðœ. Ð¡Ñ‚ÐµÐ°Ñ‚Ð¾Ð· Ð¿ÐµÑ‡ÐµÐ½Ð¸ Ð¸ ÑÂÑ‚ÐµÐ°Ñ‚Ð¾Ð³ÐµÐ¿Ð°Ñ‚Ð¸Ñ‚—Ð½ÐµÐ¸Ð·Ð±ÐµÐ¶Ð½Ð¾ÑÂÑ‚ÑŒ ÑÂÐ¼ÐµÑˆÐ°Ð½Ð½Ð¾Ð³Ð¾ Ð³ÐµÐ½ÐµÐ·Ð°. Ð“Ð°ÑÂÑ‚Ñ€Ð¾ÐµÐ½Ñ‚ÐµÑ€Ð¾Ð»Ð¾Ð³iÑÂ. 2014;54(4). View at Publisher  View at Google Scholar  View at Indexing
 Lim E, Ni M, Cao S, Hazra A, Tamimi RM, et al. (2014) Importance of Breast Cancer Subtype in the Development of AndrogenReceptorDirected Therapy. Current breast cancer reports. 6: 7178. View at Publisher  View at Google Scholar  View at Indexing

ÃâÃÂ²ÃÂÃÂ³ÃÂ¸ÃÂ½Ãâ ÃÂµÃÂ²ÃÂ° ÃÂ¢Ãâ, ÃâÃÂ»ÃÆÃâ°ÃÂµÃÂ½ÃÂºÃÂ¾ ÃÂ¡Ãâ. ÃÂÃÂµÃÂ°ÃÂ»ÃÂºÃÂ¾ÃÂ³ÃÂ¾ÃÂ»ÃÅÃÂ½Ãâ¹ÃÂ¹ ÃÂÃâÃÂµÃÂ°ÃâÃÂ¾ÃÂ³ÃÂµÃÂ¿ÃÂ°ÃâÃÂ¸Ãâ ÃÂ¸ ÃÂ¼ÃÂµÃâÃÂ¾ÃÂ´Ãâ¹ ÃÂ¿ÃÂ°ÃâÃÂ¾ÃÂ³ÃÂµÃÂ½ÃÂµÃâÃÂ¸Ãâ¡ÃÂµÃÂÃÂºÃÂ¸ÃÂ¹ ÃÂºÃÂ¾Ãâ¬Ãâ¬ÃÂµÃÂºÃâ ÃÂ¸ÃÂ¸. ÃÅÃÂµÃÂ¶ÃÂ´ÃÆÃÂ½ÃÂ°Ãâ¬ÃÂ¾ÃÂ´ÃÂ½Ãâ¹ÃÂ¹ ÃÂ¼ÃÂµÃÂ´ÃÂ¸Ãâ ÃÂ¸ÃÂ½ÃÂÃÂºÃÂ¸ÃÂ¹ ÃÂ¶ÃÆÃâ¬ÃÂ½ÃÂ°ÃÂ». 2014(2):2932.
View at Publisher  View at Google Scholar  LEGHI GE, DOMENICI FA, VANNUCCHI H (2015) Influence of oxidative stress and obesity in patients with nonalcoholic steatohepatitis. Arquivos de gastroenterologia 52(3):22833. View at Publisher  View at Google Scholar  View at Indexing
 ÐÂÐ²Ð°Ð»ÑƒÐµÐ²Ð° Ð•Ð‘, Ð¢ÐºÐ°Ñ‡ÐµÐ½ÐºÐ¾ Ð•Ð˜, Ð¡ÐºÐ°Ð·Ñ‹Ð²Ð°ÐµÐ²Ð° Ð•Ð’, Ð˜Ð²Ð°Ð½Ð¾Ð² Ð¡Ð’, ÐÅ¾Ñ€Ð¸ÑˆÐ°Ðº Ð•ÐÂ, Ð›Ð°Ð¿Ð¸Ð½ÑÂÐºÐ¸Ð¹ Ð˜Ð’. ÐÑ„Ñ„ÐµÐºÑ‚Ð¸Ð²Ð½Ð¾ÑÂÑ‚ÑŒ ÑƒÑ€ÑÂÐ¾Ð´ÐµÐ¾ÐºÑÂÐ¸Ñ…Ð¾Ð»ÐµÐ²Ð¾Ð¹ ÐºÐ¸ÑÂÐ»Ð¾Ñ‚Ñ‹ Ð² Ñ‚ÐµÑ€Ð°Ð¿Ð¸Ð¸ Ð½ÐµÐ°Ð»ÐºÐ¾Ð³Ð¾Ð»ÑŒÐ½Ð¾Ð¹ Ð¶Ð¸Ñ€Ð¾Ð²Ð¾Ð¹ Ð±Ð¾Ð»ÐµÐ·Ð½Ð¸ Ð¿ÐµÑ‡ÐµÐ½Ð¸, Ð°ÑÂÑÂÐ¾Ñ†Ð¸Ð¸Ñ€Ð¾Ð²Ð°Ð½Ð½Ð¾Ð¹ ÑÂ Ð¼ÐµÑ‚Ð°Ð±Ð¾Ð»Ð¸Ñ‡ÐµÑÂÐºÐ¸Ð¼ ÑÂÐ¸Ð½Ð´Ñ€Ð¾Ð¼Ð¾Ð¼. ÐÐºÑÂÐ¿ÐµÑ€Ð¸Ð¼ÐµÐ½Ñ‚Ð°Ð»ÑŒÐ½Ð°ÑÂ Ð¸ ÐºÐ»Ð¸Ð½Ð¸Ñ‡ÐµÑÂÐºÐ°ÑÂ Ð³Ð°ÑÂÑ‚Ñ€Ð¾ÑÂÐ½Ñ‚ÐµÑ€Ð¾Ð»Ð¾Ð³Ð¸ÑÂ. 2013(11). View at Publisher  View at Google Scholar  View at Indexing

Stepanov YM (2014) Hepatic Steatosis and Steatohepatitis Is the Inevitability of Mixed Genesis. GASTROENTEROLOGY (4.54):13642.
View at Publisher  View at Google Scholar  Ð¡ÐºÐ¸Ð±Ñ‡Ð¸Ðº Ð’ÐÂ, Ð‘Ð°ÑˆÑ‚Ð° Ð“Ð’, Ð‘ÑƒÐ»Ð°Ðº ÐÅ¾Ð’. Ð¡Ð¢ÐÂÐ¢Ð˜ÐÂÐ« Ð’ Ð¢Ð•Ð ÐÂÐ¿Ð˜Ð˜ ÐÂÐ•ÐÂÐ›ÐšÐÅ¾Ð“ÐÅ¾Ð›ÑŒÐÂÐÅ¾Ð™ Ð–Ð˜Ð ÐÅ¾Ð’ÐÅ¾Ð™ Ð‘ÐÅ¾Ð›Ð•Ð—ÐÂÐ˜ Ð¿Ð•Ñ‡Ð•ÐÂÐ˜: Ð’Ð«Ð¡ÐÅ¾ÐšÐÂÐ¯ ÐÐ¤Ð¤Ð•ÐšÐ¢Ð˜Ð’ÐÂÐÅ¾Ð¡Ð¢ÑŒ Ð˜ Ð‘Ð•Ð—ÐÅ¾Ð¿ÐÂÐ¡ÐÂÐÅ¾Ð¡Ð¢ÑŒ. ÐÂÐÂÐ£ÐšÐÅ¾Ð’ÐÅ¾ÐŸÐ ÐÂÐšÐ¢Ð˜Ð§ÐÂÐ˜Ð™ ÐœÐ•Ð”Ð˜Ð§ÐÂÐ˜Ð™.:68. View at Publisher  View at Google Scholar  View at Indexing

Schneider TC, Abdulrahman RM, Corssmit EP, Morreau H, Smit JW et al. (2012) Longterm analysis of the efficacy and tolerability of sorafenib in advanced radioiodine refractory differentiated thyroid carcinoma: final results of a phase II trial. European journal of endocrinology 167(5):64350
View at Publisher  View at Google Scholar 
Hoftijzer HC (2011) Differentiated thyroid carcinoma: treatment and clinical consequences of therapy. Department of Endocrinology, Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University May 12.
View at Publisher  View at Google Scholar  Hareedy A, Mostafa R. Clinical and molecular studies on differentiated thyroid carcinoma management (Doctoral dissertation, Thyroid Research Group, Department of Endocrinology, Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University). View at Publisher  View at Google Scholar  View at Indexing

Todenhöfer T, Hennenlotter J, Schmiedel BJ, Hohneder A, Grimm S, et al. (2013) Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases. The Prostate 73(2):1628.
View at Publisher  View at Google Scholar 
Todenhöfer T, Schwentner C, Schilling D, Gakis G, Stenzl A (2011) Behandlung von ossären Metastasen und therapieinduzierter Osteoporose beim Prostatakarzinom. Der Urologe 50(9):1055.
View at Publisher  View at Google Scholar 
Grabowski GA, Golembo M, Shaaltiel Y. Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. Molecular genetics and metabolism. 2014 May 31;112(1):18.
View at Publisher  View at Google Scholar 
Castilho A, Steinkellner H (2012) GlycoÃ¢â¬Âengineering in plants to produce humanÃ¢â¬Âlike NÃ¢â¬Âglycan structures. Biotechnology journal 7(9):108898.
View at Publisher  View at Google Scholar  Elstein D, Hughes D, Gokerâ€ÂAlpan O, Stivel M, Baris HN, et al. (2014) Outcome of pregnancies in women receiving velaglucerase alfa for Gaucher disease. Journal of Obstetrics and Gynaecology Research 40(4):96875. View at Publisher  View at Google Scholar  View at Indexing

Barth BM, Shanmugavelandy SS, Tacelosky DM, Kester M, Morad SA, et al. (2013) Gaucher's disease and cancer: a sphingolipid perspective. Critical Reviews™ in Oncogenesis 18(3).
View at Publisher  View at Google Scholar  RosalesMendoza S, TelloOlea MA (2015) Carrot cells: a pioneering platform for biopharmaceuticals production. Molecular biotechnology 57(3):21932. View at Publisher  View at Google Scholar  View at Indexing
 Barranger JA, Brady RO, Grabowski GA, Mankin H, Mistry PK, et al. (2014) Position statement: National Gaucher Foundation Medical Advisory Board, January 7. American journal of hematology 89(5):4578. View at Publisher  View at Google Scholar  View at Indexing
 Mathew A. Studies on glucose tolerant βglucosidases from a novel Byssochlamys fulvaand their applications in biomass to ethanol conversion (Doctoral dissertation, Cochin University of Science and Technology). View at Publisher  View at Google Scholar  View at Indexing